Mining the Ovarian Cancer Ascites Proteome for Potential Ovarian Cancer Biomarkers
|
journal
|
December 2008 |
Gene Expression Profiles Predict Early Relapse in Ovarian Cancer after Platinum-Paclitaxel Chemotherapy
|
journal
|
March 2005 |
Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor
|
journal
|
July 1983 |
Application of systems biology principles to protein biomarker discovery: Urinary exosomal proteome in renal transplantation
|
journal
|
June 2012 |
Genomic Predictors of Outcome and Treatment Response in Breast Cancer
|
journal
|
April 2009 |
Proteomic analyses of serous and endometrioid epithelial ovarian cancers - Cases studies - Molecular insights of a possible histological etiology of serous ovarian cancer
|
journal
|
June 2013 |
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
|
journal
|
April 2009 |
Therapeutic strategies in epithelial ovarian cancer
|
journal
|
January 2012 |
Label-Free LC-MSe in Tissue and Serum Reveals Protein Networks Underlying Differences between Benign and Malignant Serous Ovarian Tumors
|
journal
|
September 2014 |
Proteomic Identification of Paclitaxel-Resistance Associated hnRNP A2 and GDI 2 Proteins in Human Ovarian Cancer Cells
|
journal
|
November 2010 |
Identification of Platinum-Resistance Associated Proteins through Proteomic Analysis of Human Ovarian Cancer Cells and Their Platinum-Resistant Sublines
|
journal
|
February 2007 |
Historical perspective of peptidomics
|
journal
|
June 2014 |
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
|
journal
|
July 2012 |
Identification and proteomic profiling of exosomes in human cerebrospinal fluid
|
journal
|
January 2012 |
Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells
|
journal
|
October 2005 |
Proteomic analysis of post-translational modifications
|
journal
|
March 2003 |
Genomic signatures to guide the use of chemotherapeutics
|
journal
|
October 2006 |
Investigation of the Ovarian and Prostate Cancer Peptidome for Candidate Early Detection Markers Using a Novel Nanoparticle Biomarker Capture Technology
|
journal
|
June 2010 |
THE CHRONOLOGY OF EARLY EPIC - (O.) Andersen, (D.T.T.) Haug (edd.) Relative Chronology in Early Greek Epic Poetry. Pp. xiv + 277, figs. Cambridge: Cambridge University Press, 2012. Cased, £60, US$99. ISBN: 978-0-521-19497-6.
|
journal
|
March 2014 |
Ovarian cancer molecular pathology
|
journal
|
June 2012 |
Comparative Proteomic Analysis of Paclitaxel Sensitive A2780 Epithelial Ovarian Cancer Cell Line and Its Resistant Counterpart A2780TC1 by 2D-DIGE: The Role of ERp57
|
journal
|
April 2009 |
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
|
journal
|
December 2008 |
Effect of Screening on Ovarian Cancer Mortality: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
|
journal
|
June 2011 |
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
|
journal
|
February 2014 |
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays
|
journal
|
April 2004 |
Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma
|
journal
|
April 2002 |
Proteomics by Mass Spectrometry: Approaches, Advances, and Applications
|
journal
|
August 2009 |
The dynamic range problem in the analysis of the plasma proteome
|
journal
|
January 2010 |
Quantitative Proteomics Analysis Identifies Mitochondria as Therapeutic Targets of Multidrug-Resistance in Ovarian Cancer
|
journal
|
January 2014 |
Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
|
journal
|
June 2010 |
Exosomes: an overview of biogenesis, composition and role in ovarian cancer
|
journal
|
January 2014 |
Toward improving the proteomic analysis of formalin-fixed, paraffin-embedded tissue
|
journal
|
August 2013 |
Proteomic analysis reflects different histologic subtypes of epithelial ovarian cancer
|
journal
|
March 2012 |
A database of mass spectrometric assays for the yeast proteome
|
journal
|
November 2008 |
Differential Exoprotease Activities Confer Tumor-Specific Serum Peptidome Patterns
|
journal
|
April 2006 |
Human Epididymis Protein 4 (HE4) Is a Secreted Glycoprotein that Is Overexpressed by Serous and Endometrioid Ovarian Carcinomas
|
journal
|
March 2005 |
Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ
|
journal
|
April 2013 |
Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids
|
journal
|
January 2013 |
CA125 surveillance increases optimal resectability at secondary cytoreductive surgery for recurrent epithelial ovarian cancer
|
journal
|
May 2011 |
Integrated Proteomic Analysis of Human Cancer Cells and Plasma from Tumor Bearing Mice for Ovarian Cancer Biomarker Discovery
|
journal
|
November 2009 |
Management Strategies for Recurrent Platinum-Resistant Ovarian Cancer
|
journal
|
January 2011 |
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays
|
journal
|
September 2004 |
The Cell of Origin of Ovarian Epithelial Tumors and the Ovarian Surface Epithelium Dogma: Does the Emperor Have No Clothes?
|
journal
|
March 1999 |
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
|
journal
|
February 2011 |
Origin and Pathogenesis of Pelvic (Ovarian, Tubal, and Primary Peritoneal) Serous Carcinoma
|
journal
|
January 2014 |
Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics
|
journal
|
November 2011 |
Prediction of optimal versus suboptimal cytoreduction of advanced-stage serious ovarian cancer with the use of microarrays
|
journal
|
September 2004 |
Mass spectrometry-based proteomics
|
journal
|
March 2003 |
Comprehensive Analysis of Conditioned Media from Ovarian Cancer Cell Lines Identifies Novel Candidate Markers of Epithelial Ovarian Cancer
|
journal
|
October 2009 |
A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation
|
text
|
January 2014 |
A Proteome Resource of Ovarian Cancer Ascites: Integrated Proteomic and Bioinformatic Analyses To Identify Putative Biomarkers
|
journal
|
January 2008 |
The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: A systematic review
|
journal
|
June 2007 |
In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome
|
journal
|
March 2014 |
A Xenograft Mouse Model Coupled with In-depth Plasma Proteome Analysis Facilitates Identification of Novel Serum Biomarkers for Human Ovarian Cancer
|
journal
|
November 2011 |
Proteogenomic characterization of human colon and rectal cancer
|
journal
|
July 2014 |
Exosome release of β-catenin: a novel mechanism that antagonizes Wnt signaling
|
journal
|
September 2010 |
Variation and genetic control of protein abundance in humans
|
journal
|
May 2013 |
Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence
|
journal
|
June 2004 |
LC−MS/MS Analysis of Ovarian Cancer Metastasis-Related Proteins Using a Nude Mouse Model: 14-3-3 Zeta as a Candidate Biomarker
|
journal
|
December 2010 |
Integrated genomic analyses of ovarian carcinoma
|
journal
|
June 2011 |
Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis
|
journal
|
December 2009 |
Proteomic analysis of microvesicles in human saliva by gel electrophoresis with liquid chromatography-mass spectrometry
|
journal
|
April 2012 |
Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer
|
journal
|
October 2005 |
Lessons from BRCA: The Tubal Fimbria Emerges as an Origin for Pelvic Serous Cancer
|
journal
|
March 2007 |
PARP Inhibitors for BRCA1/2 mutation-associated and BRCA-like malignancies
|
journal
|
January 2014 |
The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
|
journal
|
January 2010 |
Evaluating cell lines as tumour models by comparison of genomic profiles
|
journal
|
July 2013 |
A proteomic kinetic analysis of IGROV1 ovarian carcinoma cell line response to cisplatin treatment
|
journal
|
November 2007 |
Proteomic Analysis of Urinary Exosomes in Cardiovascular and Associated Kidney Diseases by Two-Dimensional Electrophoresis and LC–MS/MS
|
book
|
January 2013 |
Integrated genomic analyses of ovarian carcinoma
|
text
|
January 2011 |
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
|
journal
|
April 2005 |
Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines
|
journal
|
October 2010 |
A Novel, High-Throughput Workflow for Discovery and Identification of Serum Carrier Protein-Bound Peptide Biomarker Candidates in Ovarian Cancer Samples
|
journal
|
June 2007 |
Comparative Proteomics of Ovarian Epithelial Tumors
|
journal
|
May 2006 |
Characterization of serum biomarkers for detection of early stage ovarian cancer
|
journal
|
October 2005 |
Global quantification of mammalian gene expression control
|
journal
|
May 2011 |
In 2014, can we do better than CA125 in the early detection of ovarian cancer?
|
journal
|
January 2014 |
A randomized study of screening for ovarian cancer: a multicenter study in Japan
|
journal
|
May 2008 |
Gene Expression Signature With Independent Prognostic Significance in Epithelial Ovarian Cancer
|
journal
|
December 2004 |
Proteomic characterization of ovarian cancers identifying annexin-A4, phosphoserine aminotransferase, cellular retinoic acid-binding protein 2, and serpin B5 as histology-specific biomarkers
|
journal
|
February 2012 |
Early Detection of Ovarian Cancer: Promise and Reality
|
book
|
January 2002 |
Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship
|
journal
|
January 2007 |
Biomarker Failures
|
journal
|
January 2013 |
Mitochondrial comparative proteomics of human ovarian cancer cells and their platinum-resistant sublines
|
journal
|
March 2011 |
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
|
journal
|
April 2009 |
Glycoproteomics of paclitaxel resistance in human epithelial ovarian cancer cell lines: Towards the identification of putative biomarkers
|
journal
|
March 2010 |
Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review
|
journal
|
May 2013 |
Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics
|
journal
|
January 2012 |
Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients
|
journal
|
October 2009 |
Gene-expression profiling in epithelial ovarian cancer
|
journal
|
July 2008 |
Molecular Cloning of the CA125 Ovarian Cancer Antigen: IDENTIFICATION AS A NEW MUCIN, MUC16
|
journal
|
May 2001 |
Ovarian cancer: strategies for overcoming resistance to chemotherapy
|
journal
|
July 2003 |
Studies of the ‘hook’ effect in the one-step sandwich immunoassay
|
journal
|
July 1992 |
Functional Proteomic Analysis of Advanced Serous Ovarian Cancer Using Reverse Phase Protein Array: TGF- Pathway Signaling Indicates Response to Primary Chemotherapy
|
journal
|
May 2010 |
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
|
journal
|
July 2007 |
HE4 in ovarian cancer
|
book
|
September 2011 |
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
|
journal
|
July 2011 |
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
|
journal
|
January 2009 |
Laser-capture microdissection
|
journal
|
June 2006 |
Quantification of β-Catenin Signaling Components in Colon Cancer Cell Lines, Tissue Sections, and Microdissected Tumor Cells using Reaction Monitoring Mass Spectrometry
|
journal
|
August 2010 |
Phosphoproteomics in cancer
|
journal
|
September 2010 |
The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?
|
journal
|
January 2011 |
Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis
|
journal
|
September 2010 |
Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma
|
journal
|
November 2006 |
Reverse-phase protein lysate microarrays for cell signaling analysis
|
journal
|
October 2008 |
Extracellular vesicles: biology and emerging therapeutic opportunities
|
journal
|
April 2013 |
Comparative proteome analysis of human epithelial ovarian cancer
|
journal
|
January 2007 |
Gene Expression Patterns in Ovarian Carcinomas
|
journal
|
November 2003 |
Classifications of ovarian cancer tissues by proteomic patterns
|
journal
|
November 2006 |
Beyond chemotherapy: targeted therapies in ovarian cancer
|
journal
|
March 2009 |
Enrichment techniques employed in phosphoproteomics
|
journal
|
October 2011 |
Characterization and proteomic analysis of ovarian cancer-derived exosomes
|
journal
|
March 2013 |
Screening for Ovarian Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement
|
journal
|
December 2012 |
Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study
|
journal
|
January 2009 |
Proteomic Analysis of Ovarian Cancer Cells Reveals Dynamic Processes of Protein Secretion and Shedding of Extra-Cellular Domains
|
journal
|
June 2008 |
Three new potential ovarian cancer biomarkers detected in human urine with equalizer bead technology
|
journal
|
January 2009 |
Mitochondrial Proteomic Analysis of Cisplatin Resistance in Ovarian Cancer
|
journal
|
August 2012 |
Effectiveness of a Multivariate Index Assay in the Preoperative Assessment of Ovarian Tumors
|
journal
|
January 2011 |
The cell of origin of ovarian epithelial tumours
|
journal
|
December 2008 |
A Randomized Study of Screening for Ovarian Cancer: A Multicenter Study in Japan
|
journal
|
January 2008 |
Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma
|
journal
|
October 2013 |
Assessing the clinical utility of cancer genomic and proteomic data across tumor types
|
journal
|
June 2014 |
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases
|
journal
|
November 2011 |
Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer
|
journal
|
August 2004 |
The ovarian cancer-derived secretory/releasing proteome: A repertoire of tumor markers
|
journal
|
June 2012 |
Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
|
journal
|
January 2011 |
Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study
|
journal
|
September 2003 |
Proteomic Analysis of Malignant Ovarian Cancer Effusions as a Tool for Biologic and Prognostic Profiling
|
journal
|
February 2006 |
Highlights on the capacities of "Gel-based" proteomics
|
journal
|
January 2010 |
An overview of biomarkers for the ovarian cancer diagnosis
|
journal
|
October 2011 |
Committee Opinion No. 477: The Role of the Obstetrician–Gynecologist in the Early Detection of Epithelial Ovarian Cancer
|
journal
|
March 2011 |
Application of laser capture microdissection and proteomics in colon cancer
|
journal
|
August 2001 |
Differential exoprotease activities confer tumor-specific serum peptidome patterns
|
journal
|
December 2005 |
Kinetics of internalization and recycling of transferrin and the transferrin receptor in a human hepatoma cell line. Effect of lysosomotropic agents.
|
journal
|
August 1983 |